HEC72702
HEC72702 is a potent and orally active hepatitis B virus capsid inhibitor with an EC50 values of 0.039 µM. HEC72702 dose-dependently reduced HBV DNA in both the plasma and livers.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1793063-59-8
- Fòrmula: C24H26BrFN4O5S
- Peso molecular:581.45
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
EC50: 0.039 µM (hepatitis B virus capsid)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
>30 μM
Compound: 58; HEC72702
|
Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by manual-patch-clamp electrophysiology assay
|
[PMID: 29381358] |
| HepG2 | CC50 |
96.76 μM
Compound: 58; HEC72702
|
Cytotoxicity against human HepG2 cells by CellTiter-Blue assay
Cytotoxicity against human HepG2 cells by CellTiter-Blue assay
|
[PMID: 29381358] |
Pharmacokinetic Parameters of HEC72702 in Male Sprague-Dawley rats[1].
| dose (mg/kg) | iv (2) | po (5) |
| AUC(0-24 h) (h*ng/mL) | 4110 | 4900 |
| CL (mL/min/kg) | 8.11 | |
| VSS (L/kg) | 0.41 | |
| F % | 47.7 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:6-7 weeks, 16-18 g, Female BALB/c mice(HDI mouse model)[1]
-
Dosage:50, 100 mg/kg
-
Administration:P.o.; daily for 7 days
-
Result:Demonstrated a dose-dependent reduction of HBV DNA in the plasma of infected mice.
Chemical Information
-
No. CAS 1793063-59-8
-
Peso molecular 581.45
-
Fòrmula C24H26BrFN4O5S
-
SMILES
O=C(O)CC[C@@H]1CN(CC2=C(C(OCC)=O)[C@H](C3=CC=C(F)C=C3Br)N=C(C4=NC=CS4)N2)CCO1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Ren Q, et al. 3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. J Med Chem. 2018 Feb 8;61(3):1355-1374. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
HEC72702 Related Classifications
HY-123767 Related Classifications
Powered by Bioz